Championing
the Future of
LNP Therapeutics
Dedicated to making lipid nanoparticles (LNPs) a cornerstone of modern medicine.
The true power of lipid nanoparticles is their remarkable adaptability. As highly customizable delivery vehicles, they can transport a wide range of therapeutic cargo, including gene-editing constructs, nucleic acids, peptides, small molecules, and more. Yet, despite this versatility and their proven success, the bridge to commercialization remains challenging to cross. Currently, the LNP Alliance is tracking over 3,000 preclinical assets, yet 95% fail to reach human trials. These clinical setbacks are typically rooted in three critical areas:
Biological Performance
Insufficient potency and poor tissue targeting
Patient Safety
Persistent immunogenicity concerns
Technical Readiness
Immature processes and incomplete CMC documentation
Aligning to Advance
LNP Innovation
The LNP Alliance was formed to integrate the industry’s most needed development expertise, experience, and capabilities. By bringing together leaders in chemistry, formulation, imaging, and biology, we provide comprehensive expertise to dramatically increase the rate of clinical success.
The LNP
Alliance Offers
Access to proprietary ionizable lipids and excipients for optimized drug delivery
Expert formulation and process development to enhance LNP stability and efficacy
Integrated analytical and manufacturing capabilities for streamlined scale-up
Cryo-TEM imaging to understand nanoparticle Critical Quality Attributes (CQAs) and structural details
Biodistribution, efficacy, and toxicology evaluations in multiple animal models, including non-human primates
Meet the
LNP Alliance
Five leading companies are collaborating to advance LNP innovation and offer full development lifecycle support and expertise.
LNP Resources & Expertise
See More
Partner with the LNP Alliance
Ready to accelerate your LNP program? For more information on the LNP Alliance and partnership opportunities.